Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.

MLA

Fitzgerald, Robert K., et al. “Tezosentan, a Combined Parenteral Endothelin Receptor Antagonist, Produces Pulmonary Vasodilation in Lambs with Acute and Chronic Pulmonary Hypertension.” Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, vol. 5, no. 6, Nov. 2004, pp. 571–77. EBSCOhost, https://doi.org/10.1097/01.PCC.0000137357.52609.F0.

APA

Fitzgerald, R. K., Oishi, P., Ovadia, B., Ross, G. A., Reinhartz, O., Johengen, M. J., & Fineman, J. R. (2004). Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension. Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 5(6), 571–577. https://doi.org/10.1097/01.PCC.0000137357.52609.F0

Chicago

Fitzgerald, Robert K, Peter Oishi, Boaz Ovadia, Gregory A Ross, Olaf Reinhartz, Michael J Johengen, and Jeffrey R Fineman. 2004. “Tezosentan, a Combined Parenteral Endothelin Receptor Antagonist, Produces Pulmonary Vasodilation in Lambs with Acute and Chronic Pulmonary Hypertension.” Pediatric Critical Care Medicine : A Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 5 (6): 571–77. doi:10.1097/01.PCC.0000137357.52609.F0.